Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

Booster Vaccination Study to Assess Immunogenicity & Safety of a Dose of GSK Biologicals' Mencevax™ ACWY & 1/5th of a Dose of Mencevax™ ACWY in Subjects Primed in the DTPW-HBV=HIB-MENAC-TT-011 Study
Meningococcal Serogroups A, C, W-135 and Y Vaccine
105245
NCT00291343
Infections, Meningococcal
Phase 3
 
This is a follow up study to 100478. The results are summarized with study 105239 on the GSK Clinical Study Register. An annotated case report form is not available for this study. A blank case report form will be provided
October 2014

Powered by ideaPoint, Inc.